Health News
Approved: First Biosimilar Rx for Cancer
The US Food and Drug Administration (FDA) has approved the United States' first biosimilar drug to treat cancer.
FDA Grants Orphan Drug Status to Aldoxorubicin
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin.
Illegal Drugs Aren't the Only Kind That Kill
Avastin®, a cancer drug, has been shown to increase patient death from adverse events when used in conjunction with chemotherapy or biological therapy, according to new analysis of previous studies.